62 studies found for:    burzynski
Show Display Options
Rank Status Study
21 Unknown  Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors
Condition: Sarcoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
22 Unknown  Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
23 Withdrawn Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Stage III Prostate Cancer;   Stage IV Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1;   Drug: bicalutamide;   Drug: flutamide;   Drug: leuprolide acetate;   Procedure: alternative product therapy;   Procedure: antiandrogen therapy;   Procedure: biological therapy;   Procedure: biologically based therapies;   Procedure: cancer prevention intervention;   Procedure: complementary and alternative therapy;   Procedure: differentiation therapy;   Procedure: endocrine therapy;   Procedure: hormone therapy
24 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
Conditions: Kidney Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
25 Unknown  Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
26 Unknown  Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine
Condition: Small Intestine Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
27 Unknown  Antineoplaston Therapy in Treating Patients With Stomach Cancer
Condition: Gastric Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
28 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva
Conditions: Cervical Cancer;   Vulvar Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
29 Unknown  Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
Condition: Carcinoma of Unknown Primary
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
30 Unknown  Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
Condition: Liver Cancer
Intervention: Drug: antineoplaston A10
31 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
32 Unknown  Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
33 Unknown  Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
34 Unknown  Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
35 Unknown  Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
36 Withdrawn Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
Conditions: Stage IV Breast Cancer;   Recurrent Breast Cancer
Interventions: Drug: antineoplaston A10;   Drug: methotrexate;   Procedure: alternative product therapy;   Procedure: biological therapy;   Procedure: biologically based therapies;   Procedure: cancer prevention intervention;   Procedure: chemotherapy;   Procedure: complementary and alternative therapy;   Procedure: differentiation therapy
37 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Bladder Cancer or Stage IV Newly Diagnosed, Incurable Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
38 Unknown  Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
39 Withdrawn Antineoplaston Therapy in Treating Women With Advanced Breast Cancer
Conditions: Stage IV Breast Cancer;   Recurrent Breast Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1;   Procedure: alternative product therapy;   Procedure: biological therapy;   Procedure: biologically based therapies;   Procedure: cancer prevention intervention;   Procedure: complementary and alternative therapy;   Procedure: differentiation therapy
40 Unknown  Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years